Where Software Founders Fit in the AI Drug Discovery Startup Boom(wsj.com)
Writing language: KoreanRead in the original language
Summary / Read source ↗
- Reid Hoffman and Siddhartha Mukherji launched Manas AI, an AI drug discovery startup, with a $24.6 million seed round.
- It's a small amount compared to other companies raising $1.3 billion.
- Software founders without biotech backgrounds should focus on the underlying platform and data layers rather than competing directly in drug creation.
- If aiming to reduce researchers' time, confirm actual demand and work with colleagues who have biotech expertise.
Have you run into something like this? Tell us in a line or two what you did. You do not need to know the product.